+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

Global Market for Anti-obesity Drugs - Product Thumbnail Image

Global Market for Anti-obesity Drugs

  • Report
  • November 2023
  • 67 Pages
  • Global
From
Anti-Obesity Drugs: Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs: Global Strategic Business Report

  • Report
  • March 2024
  • 264 Pages
  • Global
From
From
From
From
Anti-obesity Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Anti-obesity Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 140 Pages
  • Global
From
From
Antiobesity Global Market Report 2024 - Product Thumbnail Image

Antiobesity Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Lifestyle Drugs - Global Strategic Business Report - Product Thumbnail Image

Lifestyle Drugs - Global Strategic Business Report

  • Report
  • March 2024
  • 184 Pages
  • Global
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more